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Introduction
Prior epidemiologic studies have indicated 
that unfavorable gestational conditions or 
exposures such as preeclampsia, maternal 
obesity, gestational diabetes, alcohol consump-
tion, and smoking can influence epigenetic 
profiles in placenta and potentially impact 
risk for adverse health outcomes (Blair et al. 
2013; Lesseur et al. 2014; Maccani et al. 
2010; Wilhelm-Benartzi et al. 2012). There 
is increasing concern that exposure to certain 
environmental pollutants can influence the 
risk of disease. Endocrine-disrupting chemi-
cals (EDCs) are of concern because they can 
antagonize or mimic the effects of the body’s 
endogenous hormones, such as testosterone, 
estrogen, or thyroid hormone (Birnbaum 
2013). Prenatal exposure to EDCs is particu-
larly worrisome because chemical exposure of 
a hormonally sensitive organ in early life can 
result in phenotypic organizational changes 
that may persist throughout life (Colborn et al. 
1993). Phenols and phthalates are two classes 
of suspected EDCs that have recently been 
of particular concern partly because of their 
widespread use in consumer products and high 
production volumes. Several population-based 
studies have described the exposure profiles of 
phenols and phthalates in the United States, 
including specific vulnerable subgroups such as 
pregnant women (Braun et al. 2011; Chevrier 
et al. 2013; Meeker et al. 2013; Swan 2008; 
Wolff et al. 2008; Woodruff et al. 2011).
There is accumulating evidence that 
epigenetic mechanisms play an impor-
tant role in mediating the impact of 
environmental exposures on disease risk. 
Epigenetics is the study of mitotically heri-
table and stable modifications in the regula-
tion of gene expression that occur without 
changes to the underlying DNA sequence. 
Epigenetic mechanisms include DNA meth-
ylation, histone modification, and noncoding 
RNAs (such as microRNAs). MicroRNAs 
(miRNAs) are noncoding RNAs that are 
approximately 22 nucleotides in length. In 
animals, miRNAs can regulate gene expres-
sion  post- transcriptionally by imperfect 
complementarity with a target mRNA, thereby 
inhibiting protein synthesis (Ambros 2004). 
Concentrations of phthalate metabolites in 
urine were associated with the expression of 
target genes related to trophoblast differentia-
tion and steroidogenesis in placentas collected 
from 54 women at delivery (Adibi et al. 2010), 
and miRNA expression in two placenta cell 
lines was altered following exposure to BPA 
in vitro (Avissar-Whiting et al. 2010). Several 
miRNAs have been associated with placental 
health and function, as well as pregnancy 
disorders (Morales-Prieto et al. 2014).
To date, few studies have examined 
epigenetic profiles in tissues following 
exposure to phenols or phthalates, and 
most were performed using animal models 
(Bernal and Jirtle 2010; Doshi et al. 2013; 
Kim et al. 2013; Kundakovic et al. 2013; 
Susiarjo et al. 2013). In vivo and in vitro 
studies have revealed that exposure to 
bisphenol A (BPA) can alter miRNA expres-
sion (Avissar-Whiting et al. 2010; Tilghman 
et al. 2012; Veiga-Lopez et al. 2013). Prior 
studies have demonstrated that exposure to 
BPA and other endocrine-disrupting chemi-
cals interferes with gene expression, providing 
justification for evaluating changes in the 
transcriptome (Fletcher et al. 2013; Melzer 
et al. 2011). There is also emerging evidence 
that phthalates and phenols may disrupt 
thyroid function (Boas et al. 2012). However, 
to our knowledge, no studies to date have 
examined the relationship between phthalate 
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Background: There is increasing concern that early-life exposure to endocrine-disrupting 
 chemicals (EDCs) can influence the risk of disease development. Phthalates and phenols are two 
classes of suspected EDCs that are used in a variety of everyday consumer products, including 
plastics, epoxy resins, and cosmetics. In utero exposure to EDCs may affect disease propensity 
through epigenetic mechanisms.
oBjective: The objective of this study was to determine whether prenatal exposure to multiple 
EDCs is associated with changes in miRNA expression of human placenta, and whether miRNA 
alterations are associated with birth outcomes.
Methods: Our study was restricted to a total of 179 women co-enrolled in the Harvard Epigenetic 
Birth Cohort and the Predictors of Preeclampsia Study. We analyzed associations between first-
trimester urine concentrations of 8 phenols and 11 phthalate metabolites and expression of 29 
candidate miRNAs in placenta by qRT-PCR.
results: For three miRNAs—miR-142-3p, miR15a-5p, and miR-185—we detected associations 
between ∑phthalates or ∑phenols on expression levels (p < 0.05). By assessing gene ontology 
enrichment, we determined the potential mRNA targets of these microRNAs predicted in silico 
were associated with several biological pathways, including the regulation of protein serine/
threonine kinase activity. Four gene ontology biological processes were enriched among genes 
significantly correlated with the expression of miRNAs associated with EDC burden.
conclusions: Overall, these results suggest that prenatal phenol and phthalate exposure is 
associated with altered miRNA expression in placenta, suggesting a potential mechanism of EDC 
toxicity in humans.
citation: LaRocca J, Binder AM, McElrath TF, Michels KB. 2016. First-trimester urine concen-
trations of phthalate metabolites and phenols and placenta miRNA expression in a cohort of U.S. 
women. Environ Health Perspect 124:380–387; http://dx.doi.org/10.1289/ehp.1408409
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and phenol exposure to miRNA expression in 
human tissue. Given that the placenta plays a 
critical role in fetal growth, and that the first 
trimester marks a critical period in epigenetic 
reprogramming and a vulnerable window of 
exposure, the objective of this study was to 
determine whether first-trimester exposure to 
phenols and phthalates may disrupt miRNA 
expression in the placenta.
Materials and Methods
Study population. Our study population 
consisted of women concurrently enrolled 
in two large birth cohorts, the Harvard 
Epigenetic Birth Cohort (HEBC) and the 
Predictors of Preeclampsia Study (POPS) 
at the Brigham and Women’s Hospital in 
Boston, Massachusetts. Data and biospeci-
mens for the HEBC were collected from 
June 2007 through June 2009; the cohort 
includes 1,941 mother–child dyads (Michels 
et al. 2011). The POPS study is a prospective 
study of women beginning their prenatal care 
within clinics and private practices affiliated 
with the Brigham and Women’s Hospital 
(n = 1,608) in 2007. Urine samples were 
gathered at the first prenatal visit (< 16 weeks 
gestation), and at four additional visits 
during pregnancy. Additional information 
about this cohort has been published else-
where (McElrath et al. 2012). Our initial 
study population consisted of 196 women 
enrolled in both studies who contributed a 
first-trimester urine sample between 2007 
and 2009. Subsequent miRNA experiments 
were restricted to mother–infant dyads that 
had information on infant sex, available 
placenta for RNA processing, and were not 
twins, resulting in a final sample size of 179. 
Study participant characteristics for these 179 
women are listed in Table 1, and study partic-
ipant selection is shown in Supplemental 
Material, Figure S1.
Ethics statement. The participation of 
human subjects occurred after informed 
consent was obtained. The study protocols 
were approved by the Institutional Review 
Board of Brigham and Women’s Hospital.
Urine sample collection. Urine samples 
from the first prenatal visit (< 16 weeks) were 
collected in polypropylene urine cups and 
frozen at –80°C. Before biomarker analysis, 
samples were defrosted at 4°C overnight. 
After another round of vortexing, samples 
were aliquoted to 1.6-mL polypropylene 
tubes and refrozen at –80°C. For each 
participant, one tube was shipped on dry 
ice overnight to the Centers for Disease 
Control and Prevention (CDC) for measure-
ment of urinary concentrations of phthalate 
metabolites and phenols. To adjust for urine 
dilution, specific gravity (SG) was measured 
at Brigham and Women’s Hospital. SG 
was measured using a handheld refractomer 
(Atago, Bellevue, WA), which was calibrated 
with deionized water before each measure-
ment. We adjusted for urine dilution using 
SG, rather than urinary creatinine, which 
is likely altered by stage of pregnancy 
(Cunningham et al. 2005). 
Urinary phthalate and phenol concentra‑
tions. Urinary concentrations of 8 phenols 
and 11 phthalate metabolites were measured 
using the on-line solid phase extraction–
high performance liquid chromatography–
isotope dilution–tandem mass spectrometry 
approaches described previously (Silva et al. 
2008; Ye et al. 2005). We measured concen-
trations of total (free plus conjugate) species. 
Quality control materials, prepared at 
the CDC with pooled human urine, were 
analyzed in each batch along with standard, 
blank, and study samples. The limit of detec-
tion (LOD) ranged from 0.2 to 1.2 μg/L 
for phthalates and from 0.2 to 2.3 μg/L for 
phenols. Urinary concentrations below the 
LOD were imputed a value equal to one-half 
of the LOD (Hornung and Reed 1990). 
We chose the first trimester as our exposure 
window because early gestation marks a 
critical and vulnerable period for the develop-
ment of epigenetic profiles (Langley-Evans 
et al. 2012).
Sample preparation and RNA isolation. 
All placenta samples used in this study were 
taken from the upper layer near the umbilical 
cord (near upper; NU). Using the mirVANA 
RNA Isolation Kit (Ambion Inc., Austin, 
TX), miRNA-containing RNA was isolated 
according to the manufacturer’s protocol.
miRNA selection. We performed a pilot 
project to identify miRNAs to be differen-
tially expressed across a subset of 48 samples. 
The 48 samples represented the highest and 
lowest quintiles of exposure for phthal-
ates and phenols. The pilot study analyzed 
86 miRNAs among the 48-sample subset 
using Qiagen miFinder PCR Arrays (see 
Supplemental Material, Table S1). We 
chose to validate candidate miRNAs that 
were statistically significantly associated with 
additive phenol and phthalate concentra-
tion groups. The miRNAs analyzed in this 
study are listed in Supplemental Material, 
Table S2. miRNAs were measured using 
specially designed Qiagen PCR Arrays, which 
have extremely high reproducibility, thereby 
eliminating the need for technical triplicates. 
Example triplicate reproducibility for the 
miRNAs assessed in this project is shown in 
Supplemental Material, Figure S2. For the 4 
samples with microRNAs measured in tripli-
cate, between 71% and 84% of the expression 
measurements had a coefficient of variation 
(CV) < 1. In one sample, reproducibility was 
lower (CV > 5) for 2 miRNAs (miR-125b-5p 
and miR-30a-5p), but the reproducibility of 
these measurements was strong for all other 
samples (CV < 1). The relative distribution 
of phthalates and phenols was similar for 
both the pilot project and the main study (see 
Supplemental Material, Figure S3). The range 
of metabolite values in the pilot captured the 
range of values measured in the entire study. 
The reproducibility of miRNA expression 
between the pilot study and the main study is 
shown in Supplemental Material, Figure S4, 
demonstrating consistency. The correlation 
in expression values measured in the pilot and 
main study ranged from moderate to strong 
(r = 0.43 to 0.82), with approximately 50% 
having an r ≥ 0.6. Two miRNAs showed poor 
correlation between the two study stages, 
miR-128 and miR-155-5p. Additionally, 
these two miRNAs had two samples that were 
outliers. The sensitivity to the inclusion of 
these possibly influential points was assessed 
in the final models. The full study analyzed 
29 miRNAs chosen from the pilot project 
that were found to be differentially expressed 
across a subset of 48 samples.
Real time quantitative reverse transcrip‑
tion polymerase chain reaction (qRT‑PCR). 
All RNA quality was assessed using the 
nanodrop ND-1000 (NanoDrop), and all 
RNA used had passing 260/280 values, 
which was defined as ≥ 1.8. Using the 
miScript II RT Kit (Qiagen), 250 ng cDNA 
Table 1. Study participant characteristics.
Characteristic n (%) 
Ethnicity
White non-Hispanic 126 (70.39)
Hispanic or Latino 25 (14.00)
Asian/Pacific Islander 5 (2.79)
Black/African American 23 (12.85)
Infant sexa
Female 94 (51.51)
Male 85 (47.49)
Maternal smoking during pregnancy
No 174 (97.21)
Yes 5 (2.79)
Prepregnancy body mass indexa,b 25.45 ± 5.74
Maternal age (years)a 32.91 ± 5.01
Method of deliveryb (nmiss = 6)
Spontaneous 36 (20.81)
Induced 27 (15.61)
Cesarean section 110 (63.58)
Maternal complicationsb (nmiss = 34)
Preeclampsia 1 (0.69)
Pregnancy-induced hypertension 7 (4.83)
Gestational diabetes 9 (6.21)
Infections 3 (2.07)
Parity 
Nulliparous 64 (36.16)
1 66 (37.29)
2 32 (18.08)
≥ 3 15 (8.47)
Gravidity
0 46 (26.74)
1 44 (25.58)
2 38 (22.09)
≥ 3 44 (25.58)
nmiss, number with missing information.
aMean ± SD. bChart-abstracted. 
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was reverse-transcribed from RNA according 
to the manufacturer’s instructions. The PCR 
reaction condition was as follows: incubated 
at 25°C for 10 min, 37°C for 120 min, 
and 85°C for 5 min. The qRT-PCR was 
performed using the miScript SYBR® Green 
PCR Kit (Qiagen) and custom designed 
miScript PCR arrays (Qiagen) according 
to manufacturer’s instructions on a Life 
Technologies 7900HT qPCR machine at 
the Harvard Medical School ICCB Screening 
Facility with reverse transcription controls. 
The qRT-PCR cycling conditions were as 
follows: 95°C for 15 min, and 40 cycles of 
94°C for 15 sec, 55°C for 30 sec, and 70°C 
for 30 sec. All qRT-PCR data were normal-
ized using the average of two small nucleolar 
RNAs, SNORD61 and SNORD95. Delta Ct 
(ΔCt) was defined as the expression difference 
between the target miRNA and the average 
of the two normalizing nucleolar RNAs: 
ΔCt = Ctnormalizing RNA – CtmirRNA.
Statistical analysis. Phthalate body 
burden was defined by four classifications: 
Σphthalates (the sum of all phthalates), high 
molecular weight (HMW), low molecular 
weight (LMW), and DEHP [di(2-ethyl-
hexyl) phthalate] metabolites. Phenol body 
burden was defined by three classifications: 
Σphenols (the sum of all phenols), paraben, 
and non-paraben. MicroRNAs were modeled 
as a function of each log-transformed EDC 
body burden measurement, adjusting for 
maternal age, maternal ethnicity, and self-
reported maternal smoking (yes/no), and 
infant sex. Effect modification by infant 
sex was assessed by incorporating an inter-
action term between EDC level and infant 
sex into our models. In the case of a signifi-
cant interaction, determined by a Wald test, 
the association between EDCs and miRNA 
levels was reported separately for male and 
female infants. If infant sex was not a signifi-
cant modifier, the association was reported 
for male and female infants together. 
Although we have previously observed that 
individual phthalate and phenol biomarker 
concentrations are significantly correlated 
with one another in their respective chemical 
groups, we have also observed that phthalate 
body burden is not strongly correlated 
with phenol body burden in first-trimester 
urines (LaRocca et al. 2014). Phthalates and 
phenols may differentially affect epigenetic 
modifications, and the combined effect of 
these multiple chemical exposures is currently 
unknown. To investigate potential additive 
synergism or antagonism, we reanalyzed 
each adjusted model for miRNA level, 
including a main effect for both Σphenols and 
Σphthalates, as well as an interaction term 
between these summations. For all models, 
significance was determined using an alpha 
level of 0.05.
MicroRNA targets were predicted in silico 
and based on correlations with gene expres-
sion across the genome. The miRNA target 
prediction algorithm miRWALK (http://zmf.
umm.uni-heidelberg.de/apps/zmf/mirwalk/
micrornapredictedtarget.html) was used to 
predict targets for miRNA of interest (Dweep 
et al. 2011). Target prediction included a 
comparative analysis by four other prediction 
programs, miRanda, miRDB, TargetScan, 
and RNA22. To be considered a predicted 
target for further investigation, the target 
must have appeared in at least four of five 
prediction programs, and have a TargetScan 
Total context+ score of < 0 (Grimson et al. 
2007; Lewis et al. 2005). These scores rank 
expected response based on predicted seed-
pairing stability, target-site abundance, 
local A–U content, the location of the site 
within the 3´UTR, and 3´-supplementary 
pairing. Gene ontology (GO) enrichment for 
biological processes associated with at least 
10 genes was assessed among the list of all 
the in silico predicted targets of the miRNAs 
significantly associated with EDC levels. To 
account for GO topology, the Fisher exact 
test p-values were conditioned on neighboring 
terms (Alexa et al. 2006, 2010). Additionally, 
suspected miRNA targets were identified by 
estimating the Spearman correlation between 
miRNA levels and expression across the 
genome for a subset (n = 109) of individuals 
with excellent RNA quality. Genome-wide 
expression was assessed on the Affymetrix 
GeneChip® Human Gene 2.0 ST Array at 
the Microarray Core Facility at the Dana-
Farber Cancer Institute in Boston. Signal 
intensities were processed before analysis 
using the Affymetrix Expression Consule 
Software (Affymetrix), which included robust 
multichip analysis (RMA) background correc-
tion, quantile normalization, and gene-level 
summarization of expression using median 
polish73,74. For each miRNA significantly 
associated with EDC burden, we assessed the 
Spearman correlation with all RefSeq genes, 
using a conservative Bonferroni correction to 
identify significant correlations accounting for 
multiple testing (25,642 genes, 3 miRNAs). 
GO ontology enrichment among the genes 
correlated with miRNA levels was analyzed 
similarly to the enrichment among in silico 
predicted targets.
Results
Phthalate and phenol measurements . 
Characteristics of the study population, 
including maternal age, ethnicity, smoking, 
and body mass index of 179 pregnant 
women–newborn dyads are listed in Table 1. 
We measured 11 phthalate metabolites and 8 
phenols in first trimester urine samples from 
our study participants. SG-adjusted means, 
limits of detection (LOD), and percent of 
the population above the LOD are listed in 
Tables 2 and 3. Phthalate metabolites and 
phenols were detected in ≥ 80% of samples, 
except for MEHP [mono(2-ethylhexyl) 
phthalate] (68% > LOD) (Table 2) and butyl 
parraben (BuPB) and triclosan (both with 
78% > LOD) (Table 3).
Associations between grouped phthalate 
and phenol measurements and miRNA 
expression in placenta. Two miRNAs were 
significantly associated with additive phenols, 
and miR-185 was associated with ∑LMW 
(Figure 1; see also Supplemental Material, 
Table 2. Phthalate metabolite characteristics and measurements.
Phthalate Abbreviation
Molecular weight 
(g/mol)
High/low 
MW Parent compound
LOD 
(μg/L)
GM 
(μg/L)
GM 
(mol/L)
% above 
LOD
Mono(2-ethyl-5-carboxypentyl) phthalate MECPP 308.33 High Di(2-ethylhexyl) phthalate (DEHP) 0.6 41.78 133.56 100
Mono(2-ethyl-5-hydroxyhexyl) phthalate MEHHP 294.34 High DEHP 0.7 29.87 99.73 98.87
Mono(2-ethyl-5-oxohexyl) phthalate MEOHP  292.32 High DEHP 0.7 18.39 61.54 97.74
Mono(2-ethylhexyl) phthalate MEHP 278.34 High DEHP 1.2 4.38 15.70 68.36
Mono(3-carboxypropyl) phthalate MCPP 252.22 High Dioctyl phthalate (DOP) 0.2 1.40 5.45 84.75
Mono(2,6-dimethyl-6-carboxyhexyl) phthalate MCOP 322.35 High Diisononyl phthalate (DiNP) 0.7 6.85 20.08 94.92
Mono(2,7-dimethyl-7-carboxyheptyl) phthalate MCNP 336.38 High Diisodecyl phthalate (DiDP) 0.6 2.01 5.82 80.23
Monobenzyl phthalate MBzP 256.25 High Benzylbutyl phthalate (BzBP) 0.3 5.34 20.14 97.18
Mono-isobutyl phthalate MiBP 222.24 Low Diisobutyl phthalate (DiBP) 0.6 5.74 24.84 94.92
Mono-n-butyl phthalate MnBP 222.23 Low Dibutyl phthalate (DnBP) 0.6 13.05 57.25 97.18
Monoethyl phthalate MEP 194.18 Low Diethyl phthalate (DEP) 0.8 85.00 432.68 100
Abbreviations: GM, geometric mean; LOD, limit of detection; MW, molecular weight. Concentrations < LOD were assigned a value equal to one-half the LOD. Correction factors of 0.66 
for MEP and 0.72 for MBzP were applied due to analytic standards of inadequate purity. Summed HMW phthalates include all phthalates listed as “high”; summed LMW phthalates 
include all phthalates listed as “low”; and summed DEHP metabolites include all phthalates with DEHP listed as the parent compound.
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Tables S3 and S4). A log(mol/L) increase in 
Σphenols was associated with a 0.13 [95% 
confidence interval (CI): –0.23, –0.03] 
decrease in miR-142 ΔCt. Expression of 
miR-142 seemed to be induced by the 
nonparabens, which were also significantly 
associated this miRNA (–0.09; 95% CI: 
–0.17, –0.02). Modeling miRNA expression 
as a function of each phenol independently, 
it appeared that the association with these 
estimates of phenol burden may be driven 
by benzophenone-3 (BP-3) exposure (–0.08; 
95% CI: –0.14, –0.02; see Supplemental 
Material, Figure S5). Evaluation of the 
contribution of any individual metabolite 
is complicated by the concurrence of these 
compounds in consumer products, and 
different compounds may not share similar 
modes of action, and therefore must be inter-
preted with caution. Previously, we reported 
a significant weak inverse correlation between 
BP-3 and 2,5-dichlorophenol (2,5-DCP) 
(ρ = –0.24) and stronger positive correlation 
with BuPB (ρ = 0.28), which is also used 
in sunscreens and cosmetics (LaRocca et al. 
2014). Levels of miR-15a-5p were also found 
to significantly decrease with a log(mol/L) 
increase of Σnonparabens [–0.09 (95% CI: 
–0.16, –0.01)]. Infant sex significantly 
modified the association between miR-15a-5p 
levels and both Σphenols and Σparabens. 
An increase in the urine concentrations of 
Σphenols was associated with a significant 
decrease only in miR-15a-5p in the placenta 
among female infants (–0.22; 95% CI: 
–0.38, –0.07). We additionally detected a 
significant association between miR-128 
expression and both Σphenols and Σparabens 
(0.11; 95% CI: 0.02, 0.20 and 0.09; 95% CI: 
0.01, 0.17, respectively). However, after the 
removal of two expression outliers that could 
not be explained by the sample characteristics, 
we did not detect a significant change (0.20; 
95% CI: –0.04, 0.09 and 0.10; 95% CI: 
–0.04, 0.08, respectively). More than half 
of the miRNAs were associated (p < 0.05) 
with one of the measured phenols in our 
adjusted models (see Supplemental Material, 
Figure S5). Most of these miRNAs were 
either positively associated with BPA levels or 
negatively associated with BP-3.
We also modeled miRNA expression as 
a function of each additive phthalate group 
(Figure 1; see also Supplemental Material, 
Table S4). In contrast to phenols, only one 
miRNA was significantly associated with 
additive phthalates. A log(mol/L) increase in 
ΣLMW phthalates was significantly associated 
with a 0.10 (95% CI: –0.18, –0.01) decrease 
in miR-185 expression. This association may 
be driven by MEP (monoethyl phthalate) 
exposure, which demonstrated the strongest 
inverse association with miR-185 expres-
sion when modeled independently (–0.08; 
95% CI: –0.15, –0.01; see Supplemental 
Material, Figure S5). However, this asso-
ciation may also reflect the impact of other 
LMW compounds, MiBP (mono-isobutyl 
phthalate) and MnBP (mono-n-butyl 
phthalate), which have a significant moderate 
positive correlation with MEP (LaRocca et al. 
2014). Infant sex did not modify the asso-
ciation between any miRNA and phthalate 
summation. Ten of the miRNAs were asso-
ciated (p < 0.05) with at least one of the 
individual phthalates (see Supplemental 
Material, Figure S5). A majority of these 
miRNAs were associated with at least MCOP 
(monocarboxyisooctyl phthalate).
Finally, we investigated a possible additive 
interaction between phthalates and phenols 
together on placenta miRNA expression. 
The interaction between Σphenols and 
Σphthalates on expression was not significant 
for any of the miRNAs (data not shown).
Predicted mRNA targets and potentially 
affected pathways. In silico target prediction 
software was used among mRNA (messenger 
RNA) targets of the three miRNAs that 
were significantly associated with phenol or 
phthalate levels (miR-185, miR-142-3p, miR-
15a-5p). We investigated biological process 
enrichment among the genes that had at least 
four databases linking them to one of the 
three miRNAs. Table 4 lists the 19 biological 
pathways enriched among these putative 
mRNA targets. The genes with expression 
significantly correlated with at least one of 
the miRNA associated with EDC burden 
showed near significant (q = 0.07) enrichment 
for bicarbonate transport after adjusting for 
multiple testing (Table 5, Figure 2). For each 
miRNA, we additionally identified potential 
targets based on significant Spearman correla-
tions between miRNA levels and expression 
across the genome (25,642 RefSeq genes). 
Table 3. Phenol characteristics and measurements.
Phenol Abbreviation
Molecular 
weight
Paraben 
(yes/no)
LOD 
(μg/L)
GM 
(μg/L)
GM 
(mol/L) % > LOD
2,4-Dichlorophenol DCP 163.00 No 0.2 0.59 3.59 80.23
2,5-Dichlorophenol 2,5-DCP 163.00 No 0.2 3.91 23.62 96.05
Benzophenone-3 BP-3 228.26 No 0.4 100.08 424.10 100
Bisphenol A BPA 228.29 No 0.4 1.36 5.97 86.44
Butyl paraben BuPB 194.23 Yes 0.2 1.88 10.03 77.97
Methyl paraben MePB 152.15 Yes 1.0 187.95 1227.27 100
Propyl paraben PrPB 180.20 Yes 0.2 44.66 246.58 98.31
Triclosan TCS 289.54 No 2.3 16.34 52.68 77.97
Abbreviations: GM, geometric mean; LOD, limit of detection. Concentrations < LOD were assigned a value equal to 
one-half the LOD.
Figure 1. Significant associations between miRNA expression and EDC burden for (A) phenols and 
(B) phthalates. Blue =  female; red = male; orange = overall. Association was plotted for males and 
females separately if there was a significant interaction between EDC burden and infant sex on miRNA 
levels. Estimated change in ∆Ct for a 1-unit increase in log(mol/L) EDC burden adjusting for maternal age, 
maternal ethnicity, and self-reported maternal smoking (yes/no), and infant sex, as well as 95% CI (see 
Supplemental Material, Tables S3 and S4). *p < 0.05 in adjusted model. 
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After adjusting for multiple testing, 10 genes 
were found to be significantly correlated 
with miR-142-3p, 20 were correlated with 
miR-185, and miR-15a-5p was not associated 
with any genes (see Supplemental Material, 
Figure S6). In all cases, miRNA levels were 
inversely correlated with gene expression, with 
Spearman correlations ranging between –0.58 
and –0.46. None of these genes overlapped 
with the putative targets predicted in silico.
Associations with birth outcomes . 
Although individual EDC concentrations 
were not associated with birth outcomes in 
this cohort (LaRocca et al. 2014), we wanted 
to evaluate whether the three miRNAs that 
were significantly associated with EDC levels 
were in turn associated with birth outcomes. 
However, we did not observe any associa-
tions between miRNA expression and gesta-
tional age, birth weight, or birth length 
in our adjusted models (see Supplemental 
Material, Table S5).
Discussion
To our knowledge, this study is the first of 
its kind to identify the associations between 
prenatal phthalate and phenol exposure and 
miRNA expression in placenta. Recently, 
there has been an increased focus on the study 
of the suspected EDCs phthalates and phenols 
because of their high production volumes 
and wide-spread use in consumer products. 
Our results add to the body of evidence that 
epigenetic mechanisms are important modes 
of action in response to adverse gestational 
environments, specifically with EDC exposure.
The rationale for analyzing miRNA 
expression in placenta tissue was based 
on several factors. It has previously been 
suggested that several EDCs have the ability 
to cross the placental barrier (Takahashi and 
Oishi 2000). The placenta plays a critical role 
in fetal growth by performing many critical 
physiological functions, including mediating 
the exchange of respiratory gases, water, and 
nutrients, and acting as an endocrine organ 
to produce a number of hormones, cyto-
kines, and signaling molecules (Jansson and 
Powell 2007). It is believed to be important 
in the development of pregnancy complica-
tions, given its role in regulating exchange 
between maternal and fetal blood and nutri-
ents. Importantly, one of the few prior studies 
to investigate the effects of BPA on miRNA 
expression was performed in placenta cell 
lines (Avissar-Whiting et al. 2010).
We found several individual phenols 
and phthalates to be associated with miRNA 
expression in placenta. However, considering 
Table 4. Gene ontology (GO) biological processes among genes predicted in silico to be targeted by 
miRNAs associated with EDC burden (miR-185, miR-142-3p, miR-15a-5p).
GO term Annotated Significant Expected p-Value
FDR 
q-value
Ubiquitin-dependent protein catabolic process 403 39 17.43 3.50E-06 0.08
Regulation of protein serine/threonine kinase activity 366 35 15.83 1.90E-05 0.22
Positive regulation of small GTPase mediated signal 
transduction
30 8 1.3 2.90E-05 0.22
Positive regulation of protein insertion into mitochondrial 
membrane involved in apoptotic signaling pathway
26 7 1.12 8.80E-05 0.51
Heterophilic cell–cell adhesion 29 7 1.25 1.90E-04 0.88
Insulin-like growth factor receptor signaling pathway 32 8 1.38 2.60E-04 0.93
Axonal fasciculation 15 5 0.65 3.10E-04 0.93
Negative regulation of cellular macromolecule 
biosynthetic process
948 64 41 3.20E-04 0.93
Cellular response to insulin stimulus 207 20 8.95 5.40E-04 1.00
Regulation of sodium ion transmembrane transport 25 6 1.08 5.60E-04 1.00
Regulation of translational elongation 10 4 0.43 5.90E-04 1.00
Protein dephosphorylation 140 16 6.05 6.20E-04 1.00
Metencephalon development 84 13 3.63 6.20E-04 1.00
Embryonic epithelial tube formation 106 13 4.58 6.50E-04 1.00
Positive regulation of mesenchymal cell proliferation 36 7 1.56 7.60E-04 1.00
Platelet-derived growth factor receptor signaling pathway 36 7 1.56 7.60E-04 1.00
Smooth muscle tissue development 18 5 0.78 8.00E-04 1.00
Negative regulation of cell proliferation 529 39 22.88 9.80E-04 1.00
Neuron projection guidance 347 30 15.01 9.90E-04 1.00
FDR, false discovery rate.
Table 5. Gene ontology (GO) biological processes among genes significantly correlated with miRNA 
associated with EDC burden (miR-185, miR-142-3p, miR-15a-5p).
GO term Annotated Significant Expected p-Value
FDR 
q-Value
Bicarbonate transport 26 3 0.03 3.10E-06 0.07
Hemoglobin metabolic process 10 2 0.01 5.50E-05 0.64
Iron ion homeostasis 84 3 0.1 1.10E-04 0.85
Small molecule metabolic process 2,610 7 2.99 1.84E-03 1.00
FDR, false discovery rate.
Figure 2. Gene ontology (GO) enrichment. Genes contributing to the enrichment (unadjusted p < 0.0001) of biological processes among predicted targets of 
miRNAs associated with EDC burden (miR-185, miR-142-3p, miR-15a-5p). Color corresponds to the miRNA(s) targeting the gene. 
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that women are concurrently exposed to 
several phthalates and phenols simultaneously, 
we used a continuous summative measure-
ment of specific EDC categories of compounds 
with demonstrated shared variation, such as 
HWM phthalates. Although three miRNAs 
were significantly associated with phthalates 
or phenols, no significant interactions among 
phthalates and phenols on miRNA was 
observed. Our data do not indicate any syner-
gistic or antagonistic impact of phthalate and 
phenol burden on miRNA levels.
We found three miRNAs for which we 
detected a significant association with either 
phenol or phthalate levels on expression: miR-
142-3p, miR15a-5p, and miR-185. We input 
these three miRNAs into our in silico analyses 
to investigate potential targets and affected 
pathways. Gene enrichment analysis revealed 
several biological processes associated with 
the potential mRNA targets of these three 
miRNAs. These processes included regula-
tion of protein serine/threonine kinase activity 
and positive regulation of protein insertion 
into mitochondrial membrane involved in 
apoptotic signaling pathway. Serine/threo-
nine kinase activity is a major component of 
the apoptotic pathway. Importantly, prior 
research has demonstrated that exposure 
to physiologically relevant levels of BPA 
induces apoptosis in human cytotrophoblasts 
(Benachour and Aris 2009). Additionally, 
phthalate exposure has been implicated in 
oxidative stress in placental cells (Tetz et al. 
2013), and MEHP is a well-known Sertoli 
cell toxicant that disrupts germ cell apoptosis 
following early-life exposure in rats (Richburg 
and Boekelheide 1996).
Other biological processes that were asso-
ciated with the overall list of potential mRNA 
targets included cellular response to insulin 
stimulus and insulin-like growth factor 
receptor signaling pathway. Importantly, 
gestational diabetes has been implicated 
in abnormal insulin receptor signaling in 
placenta (Colomiere et al. 2009). Other 
targeted processes include the regulation of 
metencephalon development, and embryonic 
epithelial tube formation. Overall, our data 
indicate that prenatal phthalate and phenol 
exposure may interfere with several biological 
processes that have been previously implicated 
in placental and fetal health.
Additionally, differential expression 
of miR-185 has been observed in placenta 
samples from preeclamptic pregnancies 
compared with non-preeclamptic pregnancies 
(Ishibashi et al. 2012; Wang W et al. 2012). 
Prior research indicates that oxidative stress 
in placentas from preeclamptic pregnancies 
leads to compromised calcium homeostatis, 
and preeclampsia has also been associated 
with disrupted iron ion homeostasis (Haché 
et al. 2011; Rayman et al. 2002). Our data 
indicate that the biological processes among 
genes significantly correlated with miRNA 
associated with phthalate and phenol burden 
include iron ion homeostasis and small 
molecule metabolic process. The placenta is 
the site of exchange between the mother and 
fetus, and the placenta transports calcium 
ions actively, and is a site of metabolism for 
small amino acids (Pitkin 1985). Disruption 
of these pathways may negatively affect the 
health of the placenta and fetus. miR-185 
may represent a critical target in mediating 
these processes as a result of an adverse 
gestational environment, because its expres-
sion is increased in preeclamptic placentas 
compared with healthy pregnancies, and is 
increased in placentas from our study with 
higher phthalate and phenol exposure levels 
compared with lower exposure levels. Several 
other miRNAs that were analyzed in this 
study have been associated with other expo-
sures as well. For instance, maternal smoking 
has been associated with downregulation of 
mir-16 in human placenta (Maccani et al. 
2010). Exposure to particulate matter has 
been associated with altered expression of 
miR-128 (Bollati et al. 2015). Additionally, 
exposure to perfluorooctanoic acid is associ-
ated with circulating miR-26b levels in fluoro-
chemical plant workers (Wang J et al. 2012).
A limitation of this study is the use of a 
single urine measurement. Several prior studies 
have reported estimates of reproducibility of 
select phthalate and phenol biomarker concen-
trations in pregnant women and women of 
reproductive age (Adibi et al. 2008; Braun 
et al. 2012; Peck et al. 2010). Although 
paraben levels exhibit some variability, a 
single urine measurement during pregnancy 
may suitably represent gestational exposure 
(Smith et al. 2012). Reproducibility in 
phthalate biomarker measurements also varies 
depending on the study and chemical (Adibi 
et al. 2008; Irvin et al. 2010). Other environ-
mental or hormonal exposures not analyzed in 
this study may also confound miRNA expres-
sion. Cellular heterogeneity also represents 
another limitation of the study. Differences 
in cell populations can affect methylation in 
blood, and there are currently reference-free 
methods to adjust for cellular heterogeneity 
(Houseman et al. 2012, 2014). However, to 
date there are no methods to adjust for cell 
populations in the placenta, and dispari-
ties in methylation due to alterations in cell 
populations may reflect an outcome of EDC 
exposure, rather than a confounder. Although 
miRNA alterations following exposure to 
exogenous toxicants may not in turn cause the 
full expected transcriptional responses (Rager 
et al. 2014), we propose that the predicted 
pathway-level changes may still represent 
critical targets of EDC disruption in the 
placenta. miRNAs can target several mRNAs, 
and may affect protein level at the translational 
level rather than mRNA degradation. It is 
possible that some of the target predictions 
would be false positives in this respect. The 
genes that were significantly associated with 
miRNAs were not represented in the in silico 
analysis, which may reflect their repression 
via indirect routes or may indicate noncausal 
associations. Our study also exhibits several 
considerable strengths, the first of which was 
the measurement of EDC exposure during 
the first trimester, which represents a critical 
window of exposure for implications in adverse 
health outcomes later in life (Symonds et al. 
2007). This is also the first study of its kind to 
analyze associations between several miRNAs 
and prenatal phthalate and phenol exposure 
in humans. Notably, one study reported that 
placental miRNA is associated with early 
neurobehavioral outcomes (Maccani et al. 
2013). Given that early-life perturbations can 
influence disease development later in life, we 
propose that future research is needed to assess 
developmental outcomes during childhood 
and adulthood in this cohort.
Conclusions
Our data suggests that prenatal EDC exposure 
is associated with altered miRNA expression 
in the placenta. Given the ability for miRNAs 
to target important cellular pathways, the 
regulation of miRNAs is very important 
for placental and fetal growth. Differential 
expression of miRNAs associated with EDC 
exposure may be implicated in disrupted 
biological processes. Overall, we propose that 
miRNA regulation is a potentially significant 
epigenetic toxicity mechanism of prenatal 
phenol and phthalate exposure, which 
warrants future investigations to confirm.
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